Pentoxifylline Injection (Aoting) 0.1g/5ml × 6 Vials
1 × $2.00 
Compound L?Aspartate L?Ornithine Granules 3?g (Rigan) – Wholesale & Research Use
1 × $1.00 Subtotal: $3.00
$2.00
Fubang ATP Disodium & Magnesium Chloride Injection packs 0.1?g ATP and 32?mg MgCl? per vial, supplied in a box of 10. Manufactured by Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd. and approved under NMPA H20050737. Frequently used in experimental models of ischemia?reperfusion, shock, mitochondrial support, and microcirculatory studies.
?? For laboratory research use only.?Please consult staff for other specifications and uses?
ATP–MgCl? injection provides extracellular adenosine triphosphate complexed with magnesium, enabling rapid uptake by cells to restore intracellular energy stores. Its formula improves tissue oxygenation, stabilizes cell membranes, and assists microvascular flow in ischemic or shock conditions. Due to ATP’s short half-life, this fast-acting preparation is ideal for acute experimental interventions.
| Parameter | Details |
|---|---|
| Product Name | ATP Disodium & Magnesium Chloride Injection (Fubang) |
| Active Ingredients | Adenosine Triphosphate Disodium 0.1?g; Magnesium Chloride 32?mg |
| CAS Numbers | ATP disodium: 34369?07?8; MgCl?: 7786?30?3 / 7791?18?6 |
| Formulation | Sterile liquid injection in vial |
| Strength per Vial | 100?mg ATP + 32?mg MgCl? |
| Pack Size | 10 vials per box |
| Dosage Form | Injectable solution |
| Approval Number | H20050737 |
| Drug Standard Code | 86904069000165 |
| Manufacturer | Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd. |
| Storage Conditions | Store at 2–8?°C, protect from light and moisture |
| Intended Use | Lab research: ischemia, shock, energy metabolism, organ perfusion |
ATP–MgCl? delivers readily available ATP directly to cells, bypassing metabolic delays, while Mg²? aids in ATP activation and stabilizes cellular membranes. This combination improves microcirculation, energy support, and protects tissues in ischemic and shock models.
Ischemia–reperfusion models (liver, heart, kidney)
Hemorrhagic or septic shock experiments
Microcirculation and organ perfusion studies
Cellular energy and mitochondrial support research
Mitochondrial injury and membrane stabilization assays
Preclinical studies show improved cardiac output, reduced pulmonary artery pressure, and enhanced survival in septic and shock models after ATP–MgCl? administration.
Handling: Requires aseptic technique, lab PPE.
Storage: Maintain between 2–8?°C; protect from light.
Administration: Use promptly due to ATP’s short half-life; infuse slowly to monitor for hypotension.
Precautions: Experimental use only; improper use may cause cardiovascular effects.
ATP injection, ATP magnesium chloride injection, ATP–MgCl? 100mg, H20050737, ischemia model ATP, shock therapy research, organ perfusion ATP, laboratory ATP MgCl?
This product is for laboratory and preclinical research only. Not approved for clinical, therapeutic, diagnostic, or veterinary use. Misuse may pose legal or health risks. Use under approved institutional protocols.
| 重量 | 1 公斤 |
|---|---|
| 尺寸 | 38 × 26 × 38 厘米 |
Select at least 2 products
to compare
till –
Spero che la logistica sarà più veloce la prossima volta, grazie